体外电场热疗联合左氧氟沙星及中药灌肠治疗慢性盆腔炎合并盆腔积液50例临床观察

目的：观察体外电场热疗联合左氧氟沙星及中药灌肠治疗慢性盆腔炎合并盆腔积液的效果。方法：选择近期收治的慢性盆腔炎合并盆腔积液的患者100例,随机分为治疗组和对照组各50例,对照组采用左氧氟沙星联合中药灌肠,治疗组在对照组治疗方法的基础上,实施体外电场热疗,对比疗效。结果：治疗组临床症状改善情况显著优于对照组,差异有统计学意义（P＜0.05）。结论：慢性盆腔炎合并盆腔积液采用西药联合体外电场热疗及中药灌肠效果显著,值得推荐。     

不容小视的盆腔痛

女性朋友，你是否经常出现定期或不定期的下腹部疼痛？这是一种比痛经更为严重的疼痛——盆腔疼痛，而更可怕的是，盆腔疼痛还有可能意味着你罹患了妇科肿瘤。     

综合治疗女性慢性盆腔疼痛的效果观察

目的探讨女性慢性盆腔疼痛的有效治疗方法。方法联合采用α受体阻断剂、抗抑郁剂治疗，同时进行心理辅导和适当运动。6周为1个疗程。结果治疗组48例患者中痊愈36例，显效8例，无效4例，总有效率91．66％，明显优于对照组（60．42％）。结论联合采用α受体阻断剂、抗抑郁剂治疗同时进行心理辅导和适当运动等是治疗慢性盆腔疼痛的一种确切有效的治疗方法。     

体外高频热疗配合中药保留灌肠治疗慢性盆腔炎80例的效果观察

慢性盆腔炎是妇科常见病,多发病,其病程长,反复发作,迁延难愈,严重影响妇女的工作和学习,而对慢性盆腔炎的治疗,目前缺乏疗效肯定的药物,强调加强营养,适当锻炼等一般治疗,同时辅助中药与物理疗法。我院对慢性盆腔炎患者给予中药保留灌肠配合体外高频热疗机治疗,治疗效果满意,     

体外高频热疗仪治疗92例慢性前列腺炎的护理体会

目的探讨体外高频热疗仪治疗慢性前列腺炎的护理方法。方法对92例慢性前列腺炎进行体外高频热疗仪治疗的病人给予治疗前、治疗中、治疗后细致的护理及健康指导。结果全部病人顺利完成治疗,达到预期的疗效,其中2例病人治疗过程中腰胝部皮肤局部烫伤出现小水泡,处理后痊愈,无后遗症。结论对慢性前列腺炎病人进行体外高频热疗仪治疗时,做好细致的治疗前护理,加强治疗中密切观察及治疗后护理和健康指导,可使病人积极主动配合治疗,确保疗效,减少并发症,保障医疗安全,促进疾病痊愈。     

盆腔淤血综合征32例临床分析

目的探讨盆腔淤血综合征的临床特征、诊断、治疗及预防方法。方法回顾分析偃师市中医院共收治盆腔淤血综合征32例的临床特征、诊断、治疗方法。结果体质差,长期从事站立劳动,多产史,输卵管结扎术后,是导致本病的高危因素。32例中,轻症8例均获痊愈,重症16例痊愈,占75%。4例症状减轻,占12.5%,4例重症患者进行了手术治疗,随访2年,均获痊愈。总治愈率87.5%。结论临床症状重,阳性体征少,抗炎治疗无效是本病的特征。通过体育锻炼,产后保健,配合治疗,重症患者手术治疗,可治愈本病,重视病史及体格检查,结合辅助检查,减少误诊。     

中西医结合治疗慢性盆腔疼痛的疗效观察

目的观察中西医结合治疗慢性盆腔疼痛的疗效。方法选取80例慢性盆腔疼痛患者,分为观察组和对照组,每组各40例。对照组采用多功能盆腔治疗仪进行治疗;观察组在对照组基础上加用中药保留灌肠和化症消淤片进行治疗。结果观察组患者治疗后盆腔疼痛症状的改善效果明显优于对照组。结论中西医结合疗法治疗慢性盆腔疼痛效果非常明显。     

腹腔镜诊治慢性盆腔疼痛25例临床分析

目的了解非洲博茨瓦纳妇女慢性盆腔疼痛的病因,探讨腹腔镜对诊治慢性盆腔疼痛的临床价值。方法收集2006年6月～2007年6月在非洲博茨瓦纳玛丽娜公主医院行腹腔镜诊治的25例慢性盆腔疼痛病例并进行回顾性分析。结果25例患者中慢性盆腔炎16例(64%),子宫内膜异位症4例(16%),盆腔淤血综合征2例(8%)。术后17例患者疼痛消失,6例明显好转。结论慢性盆腔炎、子宫内膜异位症和盆腔淤血综合征是博茨瓦纳妇女慢性盆腔疼痛的主要病因,腹腔镜诊治慢性盆腔疼痛有良好效果。     

妇乐胶囊治疗慢性盆腔痛瘀热蕴结证330例

目的 观察妇乐胶囊治疗慢性盆腔痛(瘀热蕴结证)的有效性及安全性。方法 将多中心慢性盆腔痛(瘀热蕴结证)患者440例按照3:1比例分为试验组330例和对照组110例。试验组口服妇乐胶囊,每次6粒,每日2次;对照组口服金鸡胶囊,每次4粒,每日3次。两组疗程均为28 d,疗程结束后评价其有效性及安全性。结果 试验组局部体征疗效的总有效率为99.39%,明显高于对照组的83.64%(P<0.05);试验组中医证候疗效的总有效率为99.70%,明显高于对照组的82.73%(P<0.05);试验组阴道清洁度的改善率为93.01%,明显高于对照组的76.36%(P<0.05);两组患者均未见不良事件和不良反应发生。结论 妇乐胶囊治疗慢性盆腔痛(瘀热蕴结证)安全有效,疗效确切,值得临床推广。     

艾灸联合电刺激镇痛治疗慢性盆腔疼痛的效果观察

目的：观察艾灸联合电刺激镇痛治疗慢性盆腔疼痛的效果。方法对93例慢性盆腔疼痛患者采用低频神经肌肉刺激治疗仪行电刺激治疗,同时用艾条灸关元、子宫、归来、三阴交和八髎穴等穴位,治疗前后进行疼痛评分。结果经连续2个疗程治疗后,疼痛消失48例（51.6%）,疼痛缓解30例（32.3%）,无效15例（16.1%）,总有效率为83.9%。患者治疗前疼痛评分2∽8分,平均（4.85±2.32）分,治疗后0∽4分,平均（2.61±1.37）分,治疗后疼痛评分较治疗前显著降低（P〈0.01）。经半年随访,治愈的48例患者中,有9例复发需再次治疗。无明显不良反应发生。结论艾灸联合电刺激治疗慢性盆腔疼痛是一种安全、有效的治疗方法,值得推广。     

坦索罗辛治疗慢性盆底痛综合征的研究

目的:探讨坦索罗辛治疗慢性盆底痛综合征(CPPS)的有效性及安全性。方法:随机双盲对照研究,50例患者随机分为坦索罗辛组22例(0.2mg每晚1次),安慰剂对照组28例。分别在治疗开始、2周、4周、12周,治疗结束4周、8周、12周观察患者CPSI评分。结果:50例患者完成研究,治疗12周后,坦索罗辛组CPSI评分较对照组有显著的下降(分别是3.5,9.8,P<0.01);疼痛评分较对照组有显著改善(分别是1.7,6.0,P<0.01);总有效率显著高于对照组(分别是78.2%,25.1%)。在治疗结束后12周,坦索罗辛组的CPSI评分较治疗结束时有所升高,而对照组没有显著的变化(与治疗前比较CPSI总分下降分别是4.4,1.7)。结论:坦索罗辛治疗CPPS是安全、有效的,可以显著的改善患者的疼痛症状,但远期疗效不理想。     

慢性盆底疼痛综合征患者中西医结合治疗尿动力及性功能变化分析

目的探讨中西结合治疗慢性盆底疼痛综合征患者尿动力及性功能变化。方法 80例患者随机分为两组,对照组给予盐酸特拉唑嗪、安特尔口服,治疗组在对照组给药方案的基础上+前列欣胶囊口服,1个月为1个疗程。观察治疗前后患者尿动力变化及国际勃起功能障碍评分。结果两组治疗后最大尿流率及最大尿道压与治疗前比较,差异有统计学意义(P<0.05);治疗组与对照组比较治疗后最大尿流率显著升高,最大尿道压显著下降,差异有统计学意义(P<0.05)。治疗组治疗后IIEF-5评分较治疗前显著升高(P<0.05)。治疗后治疗组IIEF-5评分较对照组显著升高(P<0.05)。结论中西结合治疗可明显改善慢性盆底疼痛综合征患者尿动力和性功能。     

Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain

Chronic pelvic pain in women is a common symptom with a wide variety of etiologies that demand accurate diagnosis and appropriate treatment if pain reduction is to be effected. Superficial conditions such as provoked vestibulodynia and problems affecting deeper structures such as pelvic floor muscle spasm are difficult to treat and can have significant impacts on quality of life for the sufferer.Apart from daily pain, symptoms such as painful intercourse (dyspareunia), painful bowel motions (dyschesia) and exacerbation of period pain (dysmenorrhea) are commonly reported by patients. For inflammatory conditions, and in areas where muscle spasm is thought to contribute to pain, botulinum toxins (BoNT) are used with considerable success.For gynecological indications, there are limited data, in the form of case reports and small series, to indicate that BoNT used in the vulva may have a benefit for 3-6 months after injection of 20-40 U of BOTOX^®; for women with provoked vestibulodynia. Re-treatment is reported to be successful and side effects are limited. Controlled studies are essential to further explore this indication.For pelvic floor muscle spasm, a greater number of women have been studied and a double blind, randomized controlled study has reported a significant reduction in pelvic floor pressures with significant pain reduction for some types of pelvic pain compared to baseline. There were no differences in pain compared to the control group who had physical therapy as an intervention. Physical therapy could be used as a non-invasive first line treatment, with BoNT injections reserved for those who are refractory to treatment.In summary, BoNT treatment for a variety of gynecological indications seems successful with limited side effects, although there are minimal data, particularly in superficial vulval conditions. To allow recommendation for wider utilization of this treatment, it is essential that more research is performed to add further evidence to our current knowledge.     

腹腔镜手术联合康妇消炎栓治疗盆腔粘连合并慢性盆腔痛的临床观察

目的 探究腹腔镜手术联合康妇消炎栓治疗盆腔粘连合并慢性盆腔痛的临床效果.方法 选择2015年4月至2016年5月本院收治的盆腔粘连合并慢性盆腔痛患者94例,根据随机数字表法分为两组,每组47例.观察组实施腹腔镜手术联合康妇消炎栓治疗,对照组仅给予腹腔镜手术治疗.治疗后,比较两组患者临床疗效、盆腔疼痛程度,记录两组患者不良反应发生情况.结果 治疗后6个月,观察组NPRS评分低于对照组,组间比较,差异有统计学意义(P＜0.05);对照组治疗有效率为82.98％,明显低于观察组的95.74％,组间比较,差异有统计学意义(P＜0.05);观察组生理职能、健康状况、社会功能、精神健康、情感职能评分均高于对照组,组间比较,差异有统计学意义(P＜0.05);两组患者治疗期间均未出现明显不良反应.结论 对盆腔粘连合并慢性盆腔痛患者采用腹腔镜手术联合康妇消炎栓治疗,能有效改善患者疼痛症状,提高临床疗效与生活质量,安全性高,值得临床应用与推广.     

B型超声在女性盆腔疼痛诊断中的应用价值

目的探讨B型超声在女性盆腔疼痛诊断中的应用价值。方法对90例盆腔疼痛女性患者行B型超声检查。结果宫外孕35例,宫内早孕5例,宫内早孕并卵巢囊肿蒂扭转4例,宫内早孕并畸胎瘤2例,卵巢巧克力囊肿20例,子宫肌瘤3例,输尿管结石15例,阑尾炎6例。结论 B型超声对女性盆腔疼痛疾病可快速做出诊断,为临床诊断提供可靠信息,可成为第一线诊断工具。     

金刚藤胶囊联合胎盘组织液治疗慢性盆腔痛的疗效观察

目的 探讨金刚藤胶囊联合胎盘组织液治疗慢性盆腔痛的临床疗效.方法 选择2008年1月-2010年12月收治于我院的慢性盆腔痛患者92例,随机分为观察组和对照组,对照组采用普诵西医治疗,观察组采用金刚藤胶囊联合胎盘组织液治疗,比较治疗效果.结果经过治疗,观察组36例患者中,痊愈11例,显效13例,有效10例,无效2例,总...     

Chronic pain in urological diseases: a clinical review

Chronic pain is the central problem in a variety of urological diseases. Pain is an unpleasant sensory and emotional experience associated with either actual or potential tissue damage, or described in terms of such damage. The aim of this research was to update knowledge about the ultrastructural, clinical, psychological and therapeutic aspects of chronic pain in urological diseases, in particular in chronic pelvic syndrome. In this paper we have revisited the most significant and discussed articles published in the last twenty five years, with particular references on the 2008 European Guidelines, searching key words (chronic pelvic pain syndrome, chronic pelvic pain, chronic prostatitis, interstitial cystitis, prostatodynia, urological disease) and data with a high level of evidence. The articles that we have analyzed show that pain is characterized by an initial tissue injury that can lead to sensitization, which is a decrease in the intensity of the stimulus needed to elicit a response by the nerve, involving the peripheral and central nervous systems. The chronic pain state is characterized by loss of inhibitory interneurons, establishment of aberrant excitatory synaptic connections and long-term potentiation of response due to changes in sensitivity of nerve synapses. Stress and hormones might also play a role in central sensitization. Pain also has a cognitive and emotional component. It is very difficult to treat, given the complex nature of the response and the interaction of physiological aspects     

Treatment strategies for cancer patients with breakthrough pain

Background: Breakthrough pain (BTP) is a transitory flare of pain superimposed on an otherwise stable pain pattern in patients treated with opioids. It is normally severe in intensity, has a rapid onset, has a variable duration (on average 30 min) and is considered a negative prognostic factor. Objective: To verify the data in the literature about therapy strategies for BTP in cancer patients. Methods: To find clinical trials investigating drug therapy for BTP. Conclusion: The treatment of BTP in cancer patients receiving opioids is principally based on the use of opioids, preferentially with a short onset. Fentanyl delivered by recently developed systems seems to be the best option to cover the temporal pattern of BTP, although the treatment should be highly personalized to provide the best in individuals, balancing patients' preferences and clinical needs. The doses to be administered is still a matter of controversy in the literature; additional studies with specific designs should be conducted to settle the question.